Berberine suppresses gero-conversion from cell cycle arrest to senescence
Open Access
- 1 August 2013
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 5 (8) , 623-636
Abstract
Berberine (BRB), a natural alkaloid, has a long history of medicinal use in both Ayurvedic and old Chinese medicine. Recently, available as a dietary supplement, Berberine is reported to have application in treatment of variety diseases. Previously we observed that BRB inhibited mTOR/S6 signaling concurrently with reduction of the level of endogenous oxidants and constitutive DNA damage response. We currently tested whether Berberine can affect premature, stress-induced cellular senescence caused by mitoxantrone. The depth of senescence was quantitatively measured by morphometric parameters, senescence-associated β-galactosidase, induction of p21WAF1, replication stress (γH2AX expression), and mTOR signaling; the latter revealed by ribosomal S6 protein (rpS6) phosphorylation. All these markers of senescence were distinctly diminished, in a concentration-dependent manner, by Berberine. In view of the evidence that BRB localizes in mitochondria, inhibits respiratory electron chain and activates AMPK, the observed attenuation of the replication stress-induced cellular senescence most likely is mediated by AMPK that leads to inhibition of mTOR signaling. In support of this mechanism is the observation that rhodamine123, the cationic probe targeting mitochondrial electron chain, also suppressed rpS6 phosphorylation. The present findings reveal that: (a) in cells induced to senescence BRB exhibits gero-suppressive properties by means of mTOR/S6 inhibition; (b) in parallel, BRB reduces the level of constitutive DNA damage response, previously shown to report oxidative DNA damage by endogenous ROS; (c) there appears to a causal linkage between the (a) and (b) activities; (d) the in vitro model of premature stress-induced senescence can be used to assess effectiveness of potential gero-suppressive agents targeting mTOR/S6 and ROS signaling; (e) since most of the reported beneficial effects of BRB are in age-relate diseases, it is likely that gero-suppression is the primary activity of this traditional medicine.Keywords
This publication has 105 references indexed in Scilit:
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine MetabolismCell, 2013
- Caveolin-1, cellular senescence and age-related diseasesMechanisms of Ageing and Development, 2011
- Dose–response of berberine on hepatic cytochromes P450 mRNA expression and activities in miceJournal of Ethnopharmacology, 2011
- Increased life span from overexpression of superoxide dismutase in Caenorhabditis elegans is not caused by decreased oxidative damageFree Radical Biology and Medicine, 2011
- Apoptosis and Beyond: Cytometry in Studies of Programmed Cell Death2011
- New biomarkers probing depth of cell senescence assessed by laser scanning cytometryCytometry Part A, 2010
- Induced pluripotent stem cells and senescence: learning the biology to improve the technologyEMBO Reports, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Oxygen sensitivity severely limits the replicative lifespan of murine fibroblastsNature Cell Biology, 2003
- Telomeres shorten during ageing of human fibroblastsNature, 1990